copanlisib

copanlisib
Trade Name
Orphan Indication Extranodal marginal zone lymphoma
USA Market Approval USA
USA Designation Date 2017-02-07 00:00:00
Sponsor Bayer HealthCare Pharmaceuticals, Inc.;100 Bayer Boulevard, P. O. Box 915;Hanover, New Jersey, 07981